These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 27487401)

  • 1. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.
    White J; Swerdlow DI; Preiss D; Fairhurst-Hunter Z; Keating BJ; Asselbergs FW; Sattar N; Humphries SE; Hingorani AD; Holmes MV
    JAMA Cardiol; 2016 Sep; 1(6):692-9. PubMed ID: 27487401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
    Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
    JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study.
    Xiao W; Li Y; Zhuang Z; Song Z; Wang W; Huang N; Dong X; Jia J; Liu Z; Zhao Y; Qi L; Huang T
    Lipids Health Dis; 2024 Jun; 23(1):163. PubMed ID: 38831433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study.
    Huang X; Zhao JV
    Am J Clin Nutr; 2023 Nov; 118(5):1020-1028. PubMed ID: 37640107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study.
    Smith ML; Bull CJ; Holmes MV; Davey Smith G; Sanderson E; Anderson EL; Bell JA
    EBioMedicine; 2023 Apr; 90():104503. PubMed ID: 36870196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
    Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
    EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.
    Tragante V; Asselbergs FW; Swerdlow DI; Palmer TM; Moore JH; de Bakker PIW; Keating BJ; Holmes MV
    Hum Genet; 2016 May; 135(5):453-467. PubMed ID: 26946290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
    Lotta LA; Sharp SJ; Burgess S; Perry JRB; Stewart ID; Willems SM; Luan J; Ardanaz E; Arriola L; Balkau B; Boeing H; Deloukas P; Forouhi NG; Franks PW; Grioni S; Kaaks R; Key TJ; Navarro C; Nilsson PM; Overvad K; Palli D; Panico S; Quirós JR; Riboli E; Rolandsson O; Sacerdote C; Salamanca EC; Slimani N; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; McCarthy MI; Barroso I; O'Rahilly S; Savage DB; Sattar N; Langenberg C; Scott RA; Wareham NJ
    JAMA; 2016 Oct; 316(13):1383-1391. PubMed ID: 27701660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study.
    Hindy G; Engström G; Larsson SC; Traylor M; Markus HS; Melander O; Orho-Melander M;
    Stroke; 2018 Apr; 49(4):820-827. PubMed ID: 29535274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality.
    Yang G; Mason AM; Wood AM; Schooling CM; Burgess S
    JAMA Netw Open; 2024 Jan; 7(1):e2352572. PubMed ID: 38241044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies.
    Iwagami M; Goto A; Katagiri R; Sutoh Y; Koyanagi YN; Nakatochi M; Nakano S; Hanyuda A; Narita A; Shimizu A; Tanno K; Hozawa A; Kinoshita K; Oze I; Ito H; Yamaji T; Sawada N; Nakamura Y; Nakamura S; Kuriki K; Suzuki S; Hishida A; Kasugai Y; Imoto I; Suzuki M; Momozawa Y; Takeuchi K; Yamamoto M; Sasaki M; Matsuo K; Tsugane S; Wakai K; Iwasaki M
    Cancer Prev Res (Phila); 2022 Dec; 15(12):827-836. PubMed ID: 36040498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth Mendelian randomization analysis of causal factors for coronary artery disease.
    Tan YD; Xiao P; Guda C
    Sci Rep; 2020 Jun; 10(1):9208. PubMed ID: 32514076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
    Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
    EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
    Lotta LA; Stewart ID; Sharp SJ; Day FR; Burgess S; Luan J; Bowker N; Cai L; Li C; Wittemans LBL; Kerrison ND; Khaw KT; McCarthy MI; O'Rahilly S; Scott RA; Savage DB; Perry JRB; Langenberg C; Wareham NJ
    JAMA Cardiol; 2018 Oct; 3(10):957-966. PubMed ID: 30326043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions.
    Burgess S; Freitag DF; Khan H; Gorman DN; Thompson SG
    PLoS One; 2014; 9(10):e108891. PubMed ID: 25302496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
    Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
    Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
    Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
    Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.